ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $64,800 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 1,350,833 | $3,823,000 | 1.65% |
| Telemetry Investments, L.L.C. | 447,000 | $1,265,000 | 1.50% |
| Stonepine Capital Management, LLC | 601,580 | $1,702,000 | 0.79% |
| VR Adviser, LLC | 1,398,889 | $3,959,000 | 0.78% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $3,151,000 | 0.48% |
| Deep Track Capital, LP | 290,844 | $823,000 | 0.05% |
| FEDERATED HERMES, INC. | 5,222,250 | $14,779,000 | 0.04% |
| Alyeska Investment Group, L.P. | 972,326 | $2,752,000 | 0.03% |
| Baker Brothers Advisors | 374,395 | $1,060,000 | 0.01% |
| Virtu Financial LLC | 12,845 | $36,000 | 0.00% |